CLRB
Cellectar Biosciences, Inc.Closed1.39−0.04 −2.80%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 1.49 +7.19%
Open
1.55
Prev close
1.43
Day range
1.361.60
52-week range
1.345.07
Volume
532.57K8.15×
Mkt cap
13.14M
P/E ttm
—
Fwd P/E
-0.73
EPS ttm
-3.46
Div yield
0.00%
Earnings
Aug 13, 2026
From 52w high
−72.58%
CLRB earnings and estimates
CLRB Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 12
Before the open · estimated
EPS consensus
$−0.56
range −0.77 – −0.42
EPS growth vs year ago
+60.5%
year ago −1.41
Revenue consensus
$0
0.0% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±9.9%
average move · beat 3 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 13, 2026 BMO | −0.57 | −0.52 | −9.62% | — | −4.6% | +0.8% |
| Mar '26 | May 14, 2026 BMO | −1.33 | −1.89 | +29.44% | $0 | +8.8% | +7.8% |
| Dec '25 | Mar 4, 2026 BMO | −0.53 | −1.23 | +56.73% | $0 | +8.2% | +13.8% |
| Sep '25 | Nov 13, 2025 BMO | −1.41 | −2.53 | +44.21% | $0 | −18.0% | −18.3% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.56 | −0.77−0.42 | +60.5% | $0 | 0.0% | −0.45 −25.3% | −0.43 −30.7% | 1 / 2 |
| Next quarter Dec 2026 | −0.53 | −0.68−0.43 | −0.5% | $0 | 0.0% | −0.49 −9.2% | −0.45 −17.5% | 1 / 2 |
| Current year Dec 2026 | −2.43 | −2.64−2.13 | +70.9% | $0 | 0.0% | −2.17 −12.1% | −2.05 −18.9% | 2 / 2 |
| Next year Dec 2027 | −1.92 | −2.34−1.43 | +21.3% | $7.65M | 0.0% | −1.79 −7.1% | −1.60 −19.4% | 1 / 2 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.46 | −0.50−0.42 | 2 | 0 / 0 |
| Dec 2026 | −0.51 | −0.59−0.43 | 2 | 0 / 0 |
| Mar 2027 | −0.50 | — | 1 | 0 / 0 |
| Jun 2027 | −0.68 | — | 1 | 0 / 0 |
| Sep 2027 | −0.66 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −2.39 | −2.64−2.13 | 2 | 0 / 0 |
| Dec 2027 | −2.08 | −2.34−1.55 | 3 | 0 / 0 |
| Dec 2028 | −0.52 | — | 1 | 0 / 0 |
| Dec 2029 | 0.79 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.